Alzheimer’s Disease Drug Market Poised for Gradual Expansion by 2031
Market Analysis The global Alzheimer’s Disease Drug market is estimated to be valued at USD 3,727 million in 2024 and is projected to grow to USD 4,130 million by 2031, registering a CAGR of 1.5% during the forecast period from 2025 to 2031. Get Free Sample Report: https://www.qyresearch.in/request-sample/pharma-healthcare-global-alzheimers-disease-drug-market-insights-industry-share-sales-projections-and-demand-outlook-2025-2031?utm_source=linkedin&utm_medium=Ruchika&utm_campaign=ruchika Key Trends Include The emergence of disease-modifying therapies (DMTs) that target amyloid plaques and tau proteins is reshaping the treatment landscape. Advancements in biomarker-based diagnostics , such as blood-based tests, are enabling earlier and more accurate detection. Growing interest in digital health tools and AI-driven platforms to support diagnosis, monitor cognitive decline, and enhance clinical trial efficie...